MiR-15a, miR-16-1 and miR-17-92 cluster expression are linked to poor prognosis in multiple myeloma-Reference-Cited by-同舟云学术

MiR-15a, miR-16-1 and miR-17-92 cluster expression are linked to poor prognosis in multiple myeloma

Published:2012-12 Issue:12 Volume:36 Page:1505-1509
ISSN:0145-2126
Container-title:Leukemia Research
language:en
Short-container-title:Leukemia Research

Author:

Gao Xiao,Zhang Run,Qu Xiaoyan,Zhao Min,Zhang Sensen,Wu Hanxin,Jianyong Li,Chen Lijuan

Funder

National Natural Science Foundation of China

Natural Science Foundation of Jiangsu Province

Foundation of Jiangsu Provincial Bureau of Health

Jiangsu Province's Medical Elite Program

Scientific Research Starting Foundation for Returned Overseas Chellonese Scholars, Ministry of Education (2012)

“Liu Da Ren Cai Gao Feng” of Jiangsu Province (2009)

Jiangsu Province

BRA2011217

Priority Academic Program Development of Jiangsu Higher Education Institutions

Publisher

Elsevier BV

Subject

Cancer Research,Oncology,Hematology

Reference29 articles.

1. Genetics and cytogenetics of multiple myeloma: a workshop report;Fonseca;Cancer Res,2004

2. Deletion of 13q14 remains an independent adverse prognostic variable in multiple myeloma despite its frequent detection by interphase fluorescence in situ hybridization;Zojer;Blood,2000

3. Results of high-dose therapy for 1000 patients with multiple myeloma: durable complete remissions and superior survival in the absence of chromosome 13 abnormalities;Desikan;Blood,2000

4. Chromosome 13 abnormalities identified by FISH analysis and serum beta2-microglobulin produce a powerful myeloma staging system for patients receiving high-dose therapy;Facon;Blood,2001

5. Biological and prognostic significance of interphase fluorescence in situ hybridization detection of chromosome 13 abnormalities (delta13) in multiple myeloma: an eastern cooperative oncology group study;Fonseca;Cancer Res,2002

Cited by 69 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Role of non-coding RNAs in vulvar cancer;Current Cancer Therapy Reviews;2024-07-23

2. Epigenetic modification of miRNA in cancer;Personalized Epigenetics;2024

3. Clinical Significance of microRNAs in Hematologic Malignancies and Hematopoietic Stem Cell Transplantation;Cancers;2023-05-08

4. Non-coding RNAs and exosomal ncRNAs in multiple myeloma: An emphasis on molecular pathways;European Journal of Pharmacology;2023-02

5. Applications of noncoding ribonucleic acids in multiple myeloma patients;Clinical Applications of Non-Coding RNAs in Cancer;2022